title: Intravitreal bevacizumab for choroidal neovascularization secondary to angioid streaks.
authors.affiliation: Dipartimento di Scienze per la Salute, Università degli Studi del Molise, Via Francesco De Sanctis s.n.c., 86100 Campobasso, Italy.
authors.forename: Michele
authors.initials: M
authors.lastname: Rinaldi
authors.forename: Roberto
authors.initials: R
authors.lastname: Dell'Omo
authors.forename: Mario R
authors.initials: MR
authors.lastname: Romano
authors.forename: Flavia
authors.initials: F
authors.lastname: Chiosi
authors.forename: Ugo
authors.initials: U
authors.lastname: Cipollone
authors.forename: Ciro
authors.initials: C
authors.lastname: Costagliola
mesh_terms: D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D000793:Angioid Streaks / Q000150:complications* / Q000175:diagnosis; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D020256:Choroidal Neovascularization / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology; D005260:Female; D005451:Fluorescein Angiography; D006801:Humans; D007267:Injections; D008297:Male; D008875:Middle Aged; D011561:Pseudoxanthoma Elasticum / Q000150:complications / Q000175:diagnosis; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors; D014792:Visual Acuity; D014822:Vitreous Body
chemical_list: D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; C467484:VEGFA protein, human; D042461:Vascular Endothelial Growth Factor A; D000068258:Bevacizumab